CME Webcast Updates Physicians on Scleroderma

OSUWexnerbloglogo2014 CME Webcast Updates Physicians on Scleroderma. In many ways, scleroderma is still a mystery but today, we do have treatments that can relieve symptoms and improve outcomes. On this CME webcast, we are going to be taking a close look at scleroderma. Let me welcome today’s guests. Dr. Ali Ajam is a rheumatologist and Assistant Professor of Internal Medicine who oversees the Ohio State University Scleroderma Clinic. And Dr. Steven Dean is Professor of Internal Medicine and specialist in vascular medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: IDENTIFY classic clinical manifestations of scleroderma associated Raynaud phenomenon; and LIST medications typically used to treat scleroderma associated Raynaud phenomenon; DIAGNOSING scleroderma, and being able to order and decipher pertinent labs; and DEVELOP screening guidelines for pulmonary involvement.

You’ll also learn about the following:

  • Common presenting signs and symptoms
  • Raynaud phenomenon
  • Scleroderma mimics
  • Scleroderma and pregnancy
  • Exercise and scleroderma
  • Raynaud phenomenon and the feet

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About New Drugs for Lipid Management

OSUWexnerbloglogo2014 Learn About New Drugs for Lipid Management. Managing hyperlipidemia used to be so easy. If a patient’s total cholesterol was greater than 200, then we started them on lovastatin to reduce it. But things are a lot more complicated now. There isn’t a single cholesterol target for all patients and we have gone way beyond statins as the only game in town for cholesterol management. On this CME webcast, we’re going to update you on the newest developments in lipid management. What tests to order, who to treat and which drugs to use. Joining our moderator in the studio is cardiologist and Associate Professor of Internal Medicine, Dr. John Larry and pharmacist and Assistant Professor of Pharmacy, Melissa Snider.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW updates in approaches to treatment of dyslipidemia; DISCUSS recent evidence for non-statin lipid lowering therapies; DISCUSS place in therapy of available lipid lowering therapies; and REVIEW clinical approach to statin intolerance.

You’ll also learn about the following:

  • Patient-specific cholesterol targets
  • Multidisciplinary lipid clinics at the OSU Wexner Medical Center
  • The expanding role of pharmacists in outpatient clinical practice
  • Diet and cholesterol

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.